Clinical trial NCT04862429 - References

Breast Cancer — Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE)

Citation(s)

•   Cheung YC, Tsai HP, Lo YF, Ueng SH, Huang PC, Chen SC
  Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis. Eur Radiol. 2016 Apr;26(4):1082-9. doi: 10.1007/s00330-015-3904-z. Epub 2015 Jul 10.
•   Grimm LJ, Ryser MD, Partridge AH, Thompson AM, Thomas JS, Wesseling J, Hwang ES
  Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials. Ann Surg Oncol. 2017 Nov;24(12):3534-3540. doi: 10.1245/s10434-017-6018-9. Epub 2017 Aug 9.
•   Iotti V, Ragazzi M, Besutti G, Marchesi V, Ravaioli S, Falco G, Coiro S, Bisagni A, Gasparini E, Giorgi Rossi P, Vacondio R, Pattacini P
  Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed. Diagnostics (Basel). 2021 Mar 4;11(3). pii: 435. doi: 10.3390/diagnostics11030435.
•   Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone S 4th, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, Musonza T, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Shah HN, Degnim AC
  A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease. Ann Surg Oncol. 2017 Oct;24(10):2915-2924. doi: 10.1245/s10434-017-5927-y. Epub 2017 Aug 1.
•   Narayan AK, Keating DM, Morris EA, Mango VL
  Calling all calcifications: a retrospective case control study. Clin Imaging. 2019 Jan - Feb;53:151-154. doi: 10.1016/j.clinimag.2018.09.016. Epub 2018 Oct 5.
•   Si J, Guo R, Huang N, Xiu B, Zhang Q, Chi W, Wu J
  Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Med. 2019 Dec;8(18):7586-7593. doi: 10.1002/cam4.2623. Epub 2019 Oct 29.

Studio BoCCE: Ruolo Della Biopsia Sotto Guida CEM (Mammografia Con Mezzo di Contrasto) Nella Caratterizzazione Delle Calcificazioni Dubbie o Sospette (BIRADS R3, R4, R5) Non Associate a Masse.

Details for clinical trial NCT04862429